on AFYREN (EPA:ALAFY)
AFYREN Reports 2024 Financial Results with Stable Outlook
AFYREN has released its audited financial results for 2024, noting significant operational gains despite a net loss of €9.75 million, slightly higher than in 2023. The company's focus on continuous production is supported by various non-dilutive financing channels, including a €10 million shareholder loan.
AFYREN NEOXY, the company's plant, produced and sold several dozen tons of biobased acids, gaining validation from key global markets. The team is preparing for continuous production in 2025, which is expected to achieve EBITDA breakeven after stabilization.
A stronger CSR performance bolstered business credibility, earning a silver ECOVADIS rating. The company aims to expand operations in France and Asia, with plans for three production units by 2028.
R. P.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all AFYREN news